What question did this study set out to answer?

This research aims to evaluate the effects of mineralocorticoids on outcomes in heart failure patients, focusing on the presence of atrial fibrillation.

March 25, 2026

Mineralocorticoids and outcome improvement in heart failure patients with and without atrial fibrillation: a systematic review and a meta-analysis

Key Result

Mineralocorticoids are associated with outcome improvements in heart failure patients with and without atrial fibrillation.

Key Points

This research aims to evaluate the effects of mineralocorticoids on outcomes in heart failure patients, focusing on the presence of atrial fibrillation.
Conducted a systematic review of existing literature
Performed a meta-analysis to summarize findings
Included heart failure patients with and without atrial fibrillation
Mineralocorticoid treatment showed improvement in outcomes for heart failure patients
Benefits were observed in both patients with and without atrial fibrillation
Meta-analysis supported the efficacy of treatment across the population

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

The PROSPERO identification number is CRD420251007396.

Bookmark

Cite This Study

Corica et al. (Mon,) reported a other. Mineralocorticoids are associated with outcome improvements in heart failure patients with and without atrial fibrillation.

synapsesocial.com/papers/69c37b74b34aaaeb1a67de0b https://doi.org/https://doi.org/10.1080/14779072.2026.2650525